Enstilar NDC 50222-302

NDC codes

FDA NDC Directory

Product NDC (as listed)50222-302Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50222-0302Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
50222-302-60	50222030260	1 CAN in 1 CARTON (50222-302-60) / 60 g in 1 CANMarketed from Oct 16, 2015
50222-302-66	50222030266	2 CAN in 1 CARTON (50222-302-66) / 60 g in 1 CANMarketed from Oct 16, 2015
50222-302-91	50222030291	1 CAN in 1 CARTON (50222-302-91) / 60 g in 1 CANMarketed from Oct 16, 2015 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Enstilar
Generic name (nonproprietary): calcipotriene and betamethasone dipropionate
Active ingredients: Calcipotriene monohydrate — 50 ug/gBetamethasone dipropionate — .5 mg/g
Dosage form: Aerosol, Foam
Route: Topical
Labeler: LEO Pharma Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 207589
Marketing start: Oct 16, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)Vitamin D (Chemical structure)
Identifiers: Product ID 50222-302_0b771976-2050-4eef-bc39-3c853c7c0ac2SPL ID 0b771976-2050-4eef-bc39-3c853c7c0ac2SPL set ID d1193df2-d53f-4342-bd9d-d9cba7c89709RxCUI 1716094, 1716099UNII S7499TYY6G, 826Y60901U
Pharmacologic class: Corticosteroid; Vitamin D Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450222030260 followed by a unit qualifier and the quantity

Package 50222-0302-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 18, 2021.

Indications (excerpt from the label)

Enstilar ® (calcipotriene and betamethasone dipropionate) Foam is indicated for the topical treatment of plaque psoriasis in patients 12 years and older. Enstilar Foam is a combination of calcipotriene, a vitamin D analog, and betamethasone dipropionate, a corticosteroid, indicated for the topical treatment of plaque psoriasis in patients 12 years and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)